Hidden metastases reveal clues to colorectal cancer recurrence

Article excerpt

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict recurrence after treatment. The findings suggest these tiny, often undetectable tumor deposits could serve as a tissue-based marker of residual cancer cells, recurrence risk and chemotherapy resistance.